http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100998569-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54313 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5052 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-16 |
| filingDate | 2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100998569-B1 |
| titleOfInvention | Development of radioimmunoconjugates for the diagnosis and treatment of cancer or metastatic cancer, and cancer or metastatic cancer inhibitors using the same |
| abstract | The present invention relates to the development of a radioimmunoconjugate for the diagnosis and treatment of cancer or metastatic cancer, and to a cancer or metastatic cancer inhibitor using the same, and specifically, to a vascular endothelial growth factor receptor target antibody as a metastatic cancer marker. Radioimmunoconjugates labeled with gamma, beta, or alpha-emitting radioisotopes with similar properties maintain protein structural stability and immune activity, and efficiently adsorb to the surface of vascular endothelial cells, thereby pre-metastic sites. It can be used as a detection factor and can be usefully used for the development of radioactive or metastatic cancer inhibitors by confirming its integration in cancer tissue when administered to a cancer-causing animal model.n n n n Radioisotopes, vascular growth factor receptor target antibodies, radiopharmaceuticals for diagnosis and treatment, cancer or metastatic cancer inhibitors |
| priorityDate | 2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.